Larry Mahan

President of the Biotechnology Institute and member of the Board, Lawrence Mahan, Ph.D. specialties include technology evaluation, entrepreneur guidance and business strategy creation with a domestic and international track record in business alliance development. His expertise draws upon more than 20 years as an accomplished senior scientist in biomedical research spanning the University of California, San Diego and later, the National Institutes of Health. His research has encompassed cellular and molecular biology, pharmacology, functional genomics, proteomics, and genetic engineering in the fields neuroscience and immunology with additional experience in biomedical device engineering principals and bioinformatics. He has more than 100 published articles and abstracts, and holds four US. patents with others pending, and has been an invited speaker globally on his scientific research and industry development in the biosciences. Dr. Mahan currently serves as CEO of OB Pharmaceuticals, Inc., a late preclinical stage company developing novel therapeutics for brain injury related seizures.